Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-6-14
pubmed:abstractText
One of the benefits of neoadjuvant chemotherapy (NAC) is its ability to convert patients ineligible for breast conservative treatment (BCT) to be candidates for this treatment, although questions have been raised regarding the effectiveness of BCT in terms of loco-regional recurrence (LRR). The objective of this study is to evaluate LRR in this group and the influence of tumor characteristics in recurrence.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1532-2157
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
528-34
pubmed:meshHeading
pubmed-meshheading:20444571-Adult, pubmed-meshheading:20444571-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20444571-Breast Neoplasms, pubmed-meshheading:20444571-Female, pubmed-meshheading:20444571-Follow-Up Studies, pubmed-meshheading:20444571-Humans, pubmed-meshheading:20444571-Incidence, pubmed-meshheading:20444571-Mastectomy, Segmental, pubmed-meshheading:20444571-Middle Aged, pubmed-meshheading:20444571-Neoadjuvant Therapy, pubmed-meshheading:20444571-Neoplasm Invasiveness, pubmed-meshheading:20444571-Neoplasm Recurrence, Local, pubmed-meshheading:20444571-Neoplasm Staging, pubmed-meshheading:20444571-Predictive Value of Tests, pubmed-meshheading:20444571-Proportional Hazards Models, pubmed-meshheading:20444571-Risk Factors, pubmed-meshheading:20444571-Survival Rate
pubmed:year
2010
pubmed:articleTitle
Can we predict local recurrence in breast conserving surgery after neoadjuvant chemotherapy?
pubmed:affiliation
Breast Surgical Unit, Department of Gynaecology, Hospital Universitario Vall d'Hebron, Passeig Vall d'Hebron 119, 08035 Barcelona, Spain.
pubmed:publicationType
Journal Article